Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PLERIXAFOR EUGIA 20 MG/ML SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PLERIXAFOR EUGIA 20 MG/ML SOLUCIÓN INYECTABLE EFG

Approved

STANDARD

PLERIXAFOR EUGIA 20 MG/ML SOLUCIÓN INYECTABLE EFG

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 13, 2023
Approval ID: 4e10d8ab0258bd25
Company: Eugia Pharma (Malta) Limited
Type: Standard

Approval Details

Approval Id: 4e10d8ab0258bd25
Drug Cima Aemps Name: PLERIXAFOR EUGIA 20 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number: 88723
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2023-03-13
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 20 mg/ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Eugia Pharma (Malta) Limited

Active Ingredients

PLERIXAFOR

24 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 13, 2023

Approval ID

4e10d8ab0258bd25

Type

Standard

Back to CIMA-AEMPS Approvals